ARCHIVES

MSKCC oncologist settles insider trading case with SEC.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Two Oral Drugs For Metastatic Melanoma

June 28, 2013

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

FDA Approves Rituxan For CLL

February 19, 2010

NCI Fund Grants To Increase Minority Internet Access.

October 6, 2000

DeVita Losing Patience, Responds To Powers Letter

May 6, 1983

Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says

February 19, 1993